USPTO Examiner FIEBIG RUSSELL G - Art Unit 1655

Recent Applications

Detailed information about the 100 most recent patent applications.

Application NumberTitleFiling DateDisposal DateDispositionTime (months)Office ActionsRestrictionsInterviewAppeal
19275921PLANT-BASED EXTRACT COMPLEX COMPOSITION HAVING THE PROPERTIES FOR SUPPORTING THE RELIEF OF MUSCULOSKELETAL PAIN, ANTIBACTERIAL AND ANTI-INFLAMMATORY AND PROCESS OF MANUFACTURING THE SAMEJuly 2025November 2025Allow411NoNo
19205571METHODS TO PRODUCE PRODUCTS COMPRISING CANNABINOIDSMay 2025August 2025Allow300NoNo
19183815COMPOSITIONS AND METHODS OF ACHIEVING PAIN RELIEFApril 2025June 2025Allow101YesNo
19091737METHODS AND CHEMICAL COMPOSITIONS FOR TREATING SKIN CONDITIONS BY PROVIDING LONG LASTING SKIN PH CONTROL FOR IMPROVING SKIN BARRIER FUNCTIONMarch 2025July 2025Allow410YesNo
18907606ANTIBACTERIAL MODIFIED CHITOSAN-BASED HEMOSTATIC MATERIAL AND METHOD OF MANUFACTURING THE SAMEOctober 2024January 2025Allow301NoNo
18902831METHOD FOR TREATING AND PREVENTING ULCERATIVE COLITIS AND METHOD FOR DAI REDUCTIONSeptember 2024December 2025Allow1421YesNo
18818636CHITOSAN COMPOSITION AND METHOD OF MANUFACTURING THE SAMEAugust 2024November 2024Allow200NoNo
18796479Curcuminoid composition of Curcumin-keto, method of preparation and use thereofAugust 2024November 2024Allow310YesNo
18759705EYE HEALTH SUPPLEMENT WITH CURCUMINJune 2024September 2025Allow1411NoNo
18715154TRADITIONAL CHINESE MEDICINE COMPOSITION AND USE THEREOFMay 2024July 2025Allow1420NoNo
18674967COMPOSITIONS COMPRISING AN AMERICAN CRANBERRY EXTRACT AND PHOSPHOLIPIDSMay 2024March 2026Allow2130YesNo
18659048OKRA EXTRACT AS A SUBSTITUTE FOR CERVICAL MUCUSMay 2024August 2025Allow1500NoNo
18658120USE OF RAMIE EXTRACT IN PREPARING A COMPOSITION FOR IMPROVING THE ACTIVITY OF MITOCHONDRIA AND IMPROVING THE ACTIVITY OF TELOMERASEMay 2024September 2025Allow1700NoNo
18641861COMPOSITIONS AND METHODS FOR TREATING AND MANAGING CHRONIC INFLAMMATORY SKIN DISORDERSApril 2024July 2025Allow1421YesYes
18632657FLAMMULINA VELUTIPES PROTEOGLYCAN (FPG) AND DUAL-WAVELENGTH SCREENING METHOD AND USE THEREOFApril 2024August 2025Abandon1621NoNo
18630703COMPOSITION FOR IMPROVING SKIN MOISTURIZATION OF COMPANION ANIMALSApril 2024July 2024Allow410NoNo
18594014PROCESS OF MANUFACTURING COMPOSITION FOR THE PREVENTION AND TREATMENT OF EARLY MORTALITY SYNDROME (EMS) SHRIMPMarch 2024July 2024Allow411NoNo
18592551METHOD FOR PRODUCING A COMPLEX COMPOSITION OF TURKEY TAIL MUSHROOM EXTRACT- CHITOSANMarch 2024June 2024Allow311NoNo
18683505LIQUID-LIQUID EXTRACTION OF PURIFIED PSYCHOACTIVE ALKALOIDFebruary 2024September 2024Allow710NoNo
18437712METHODS FOR MAKING BOTANICAL EXTRACT COMPOSITIONFebruary 2024December 2025Allow2310NoNo
18424092A METHOD OF PREVENTING CADMIUM-INDUCED RENAL TOXICITY USING A PLANT PRODUCT DERIVED FROM ACHILLEA MILLEFOLIUM L.January 2024July 2024Allow610NoNo
18416129METHODS AND COMPOSITIONS FOR TREATING STRIAE DISTENSAEJanuary 2024August 2025Allow1911NoNo
18406509METHOD FOR PRODUCING THERAPEUTIC AGENT FOR SKIN LESIONS, AND THERAPEUTIC AGENT FOR SKIN LESIONSJanuary 2024March 2025Allow1510NoNo
18395180SEPARATION AND IDENTIFICATION OF MYRICETIN-3-OGALACTOSIDE FROM CASUARINA GLAUCADecember 2023October 2024Allow1011NoNo
18391502XENOGRAFT SOFT TISSUE IMPLANTS AND METHODS OF MAKINGDecember 2023March 2025Allow1510NoNo
18383606Compositions and Methods of Achieving Pain ReliefOctober 2023March 2025Allow1710YesNo
18381479MIXTURE OF CYANOBACTERIA, CHITOSAN, AND PLANT EXTRACTS FOR WOUND HEALING AND ELIMINATING PATHOGEN BACTERIAOctober 2023May 2025Abandon1940YesNo
18381542MIXTURE OF CYANOBACTERIA, CHITOSAN, AND PLANT EXTRACTS FOR WOUND HEALING AND ELIMINATING PATHOGEN BACTERIAOctober 2023August 2024Allow1020NoNo
18487635APPROACH TO SUSTAINED PRODUCTION AND DELIVERY OF NITRIC OXIDE AND S-NITROSOTHIOLSOctober 2023January 2026Allow2721NoNo
18554058Acoustically Responsive BiomaterialsOctober 2023April 2025Allow1912NoNo
18377104BEVERAGE HAVING REB D AND REB MOctober 2023January 2026Abandon2720NoYes
18475217COMPOSITIONS CONTAINING HONEY AND LANOLINSeptember 2023February 2024Allow511YesNo
18244624COSMETIC COMPOSITIONSSeptember 2023July 2025Allow2340NoNo
18365796FOOD COMPOSITION FOR PROMOTING HEIGHT GROWTH AND PHARMACEUTICAL COMPOSITION FOR PROMOTING HEIGHT GROWTH INCLUDING HUMULUS JAPONICUS EXTRACT OR GROUND HUMULUS JAPONICUS AS ACTIVE INGREDIENTAugust 2023August 2025Abandon2420NoNo
18228865FECAL MICROBIOTA TRANSPLANT COMPOSITIONS AND METHODS OF MANUFACTUREAugust 2023March 2024Allow711YesNo
18227930RAPID INDUCTION OF CELL-MEDIATED IMMUNITYJuly 2023April 2024Allow921YesNo
18220155MIXTURE OF CYANOBACTERIA, CHITOSAN, AND PLANT EXTRACTS FOR WOUND HEALING AND ELIMINATING PATHOGEN BACTERIAJuly 2023January 2025Abandon1931NoNo
18219412MACA COMPOSITIONS AND METHODS OF USEJuly 2023September 2025Allow2631NoNo
18002740COMPOSITION FOR ALLEVIATING, TREATING, OR PREVENTING MUSCULAR DISEASES, OR IMPROVING MUSCULAR FUNCTIONS, CONTAINING KOREAN MINT EXTRACT OR TILIANIN AS ACTIVE INGREDIENTJune 2023February 2026Abandon3801NoNo
18334565CANNABIDIOL COMPOSITIONS FOR THE TREATMENT OF INFLAMMATIONJune 2023June 2025Allow2411NoNo
18208490LUTEINIZING HORMONE RECEPTOR BINDING AGENTS AND LUTEINIZING HORMONE AGONISTS TO IDENTIFY, EXPAND, ABLATE AND MODIFY STEM CELLSJune 2023January 2025Allow1911YesNo
18332063METHOD FOR ISOLATION AND PURIFICATION OF MICROVESICLES FROM CELL CULTURE SUPERNATANTS AND BIOLOGICAL FLUIDSJune 2023June 2025Allow2521NoNo
18252871ANTI-INFLAMMATORY COMPOSITION COMPRISING EXTRACELLULAR VESICLES ISOLATED FROM TONSIL-DERIVED MESENCHYMAL STEM CELLS AS AN ACTIVE INGREDIENTMay 2023February 2026Abandon3301NoNo
18301946PRODUCTS AND METHODS USING A PLATELET-DERIVED HEMOSTATIC AGENT FOR CONTROLLING BLEEDING AND IMPROVING HEALINGApril 2023February 2026Abandon3410NoNo
18299797SYSTEMS AND METHODS FOR PRODUCING HEMP EXTRACTS AND COMPOSITIONSApril 2023August 2024Allow1600NoNo
18133791Method Of Treatment Or Alleviating Symptoms Of A Disorder With CannabidiolApril 2023April 2024Allow1200NoNo
18298023COMPOUNDS FOR USE IN REGULATING FOLLICLE MATURATIONApril 2023September 2024Allow1801NoNo
18127542CREATINE NUTRITIONAL SUPPLEMENTMarch 2023November 2023Allow730YesNo
18185409METHOD FOR SCAVENGING FREE RADICALS IN CELL USING CHENOPODIUM FORMOSANUM (DJULIS) EXTRACTMarch 2023September 2024Abandon1810NoNo
18115929TOPICAL CREAM-BASED COSMETIC AND WOUND HEALING FORMULATIONS AND METHODS OF USEMarch 2023June 2025Allow2721YesNo
18115927AQUEOUS EXTRACTION PROCESS OF PLANTS, METHOD THEREOF, AND PRODUCT BY PROCESSMarch 2023February 2025Abandon2411NoNo
18168249CANNABIS EXTRACTION SYSTEM AND METHODFebruary 2023June 2024Abandon1610NoNo
18150364COMPOSITIONS AND METHODS FOR TREATMENT OF ADDICTION WITHDRAWAL SYMPTOMSJanuary 2023July 2023Allow611YesNo
18092513Novel Compositions, Uses and Methods for Making ThemJanuary 2023August 2025Allow6011NoNo
18145781FORMULATIONS FOR TREATING METABOLIC SYNDROME AND INCREASING ENERGY LEVELSDecember 2022January 2026Abandon3721NoNo
18080952COMPOSITION CONTAINING PERILLA FRUTESCENS FERMENTED EXTRACT FOR PREVENTION, ALLEVIATION, OR TREATMENT OF SLEEP DISORDERDecember 2022November 2024Abandon2310NoNo
18063694METHOD FOR SKIN BRIGHTENING USING CHENOPODIUM FORMOSANUM (DJULIS) EXTRACTDecember 2022June 2024Allow1810NoNo
18075805Use of Plasma and Plasma Fractions for Improvement of Pain, Wound Healing, and Postoperative RecoveryDecember 2022February 2026Abandon3801NoNo
17927432DERMAL FILLERSNovember 2022January 2026Allow3811NoNo
17977541METHOD FOR TREATING OR ALLEVIATING AUTOIMMUNE-RELATED DISEASESOctober 2022March 2025Allow2921NoNo
18049977SYSTEMS AND METHODS FOR PRODUCING HEMP EXTRACTS AND COMPOSITIONSOctober 2022February 2023Allow411NoNo
18048980METHOD FOR IMPROVING EYE CONDITIONSOctober 2022May 2023Allow621YesNo
17964403METHODS OF TREATING EPIDERMOLYSIS BULLOSA WITH CELL-FREE AMNIOTIC FLUID COMPOSITIONSOctober 2022December 2025Allow3810NoNo
17916240COMPOSITION FOR PREVENTING, AMELIORATING OR TREATING INFLAMMATORY BOWEL DISEASE COMPRISING COMPOUND ISOLATED FROM ISODON EXCISUS AS EFFECTIVE COMPONENTSeptember 2022October 2025Abandon3601NoNo
17953619METHODS FOR IMPROVING THE QUALITY OF LIFE OF A PATIENT WITH A PEANUT ALLERGYSeptember 2022October 2025Abandon3610NoNo
17914905ORAL COMPOSITION AND METHOD FOR AMELIORATING HARSH TASTESeptember 2022September 2025Allow3511YesNo
17951483Implantable Devices Coated With Extracellular MatrixSeptember 2022August 2025Allow3510NoNo
17950733METHODS AND COMPOSITIONS FOR INHIBITING FUNGAL GROWTH IN FOOD AND COSMETIC PRODUCTSSeptember 2022August 2023Allow1121NoNo
17933224APPROACH TO SUSTAINED PRODUCTION AND DELIVERY OF NITRIC OXIDE AND S-NITROSOTHIOLSSeptember 2022August 2023Allow1111YesNo
17903284METHOD OF ENHANCING COGNITION IN INDIVIDUALS WITH AT LEAST NORMAL COGNITIONSeptember 2022November 2023Allow1421NoYes
17799784MILD CLEANSING COMPOSITION CONTAINING NEARLY SATURATED, SATURATED OR SUPERSATURATED ACTIVE INGREDIENTS AND PREPARATION METHOD THEREFORAugust 2022January 2025Allow3000NoNo
17885854FUNCTIONAL FOOD COMPOSITION FOR ENHANCING MUSCULAR FUNCTION AND MOBILITY COMPRISING LOTUS LEAF EXTRACT, AND METHOD FOR PREPARING SAMEAugust 2022September 2024Abandon2510NoNo
17793749COSMETIC COMPOSITIONS WITH PROTEIN CONCENTRATE FROM CONDITIONED MEDIUM OF ADIPOSE-DERIVED STEM CELLSJuly 2022September 2025Allow3811NoNo
17866947TOPICAL SKIN CARE FORMULATIONS COMPRISING PLANT EXTRACTSJuly 2022September 2025Abandon3831NoNo
17811371MICRO-RNA PROFILING, COMPOSITIONS, AND METHODS OF TREATING DISEASESJuly 2022December 2025Allow4132NoNo
17810600MUSHROOM-CONTAINING CHINESE MEDICINE COMPOUND COMPOSITION FOR KELOID SCAR TISSUE AND APPLICATION THEREOFJuly 2022May 2024Abandon2211NoNo
17788797SYSTEM FOR INTEGRATION INTO A FRUIT PROCESSING FACILITYJune 2022April 2024Abandon2222NoNo
17838001XENOGRAFT SOFT TISSUE IMPLANTS AND METHODS OF MAKINGJune 2022September 2023Allow1600NoNo
17831063USE OF RAMIE EXTRACT IN PREPARING A COMPOSITION FOR IMPROVING THE ACTIVITY OF MITOCHONDRIA AND IMPROVING THE ACTIVITY OF TELOMERASEJune 2022February 2024Allow2011NoNo
17828230MACA EXTRACT AND USE THEREOFMay 2022June 2023Allow1300NoNo
17748028COMPOSITION AND METHOD FOR TREATMENT OF DRY EYE SYNDROMEMay 2022July 2023Allow1411NoNo
17733370METHODS AND COMPOSITIONS FOR TREATING STRIAE DISTENSAEApril 2022October 2023Allow1810NoNo
17731636CANNABIS COMPOSITIONS AND RELATED METHODSApril 2022January 2024Abandon2101NoNo
17660848METHODS FOR MAKING BOTANICAL EXTRACT COMPOSITIONApril 2022January 2024Allow2111NoNo
17728564COMPOSITION AND METHOD FOR TREATING DYSPEPSIAApril 2022January 2024Allow2110NoNo
17711247COMPOSITIONS AND METHODS FOR TREATING SPINAL CORD INJURY AND SYNAPTIC DYSFUNCTIONApril 2022March 2024Abandon2431NoYes
17762951AMERICAN COCKROACH EXTRACT, PREPARATION THEREOF, PREPARATION METHODS THEREFOR AND APPLICATIONS THEREOFMarch 2022January 2026Allow4631NoNo
17694116ORAL COMPOSITIONS AND METHODS FOR ANIMALSMarch 2022January 2024Allow2220NoNo
17641821Hydrolysate of water soluble insect proteins and method for preparation thereofMarch 2022February 2025Allow3501NoNo
17639040COMPOSITION FOR PREVENTING OR TREATING CANCER COMPRISING ANGELICA GIGAS, ACONITUM CARMICHAELI DEBEAUX, AND ZINGIBER OFFICINALE ROSCOE MIXED EXTRACT AS ACTIVE INGREDIENTFebruary 2022August 2025Allow4120NoNo
17638269Xenogen-Free Mesenchymal Stem Cell Compositions and Methods of UseFebruary 2022May 2025Abandon3801NoNo
17677158OILS WITH ANTI-INFLAMMATORY ACTIVITY CONTAINING NATURAL SPECIALIZED PRORESOLVING MEDIATORS AND THEIR PRECURSORSFebruary 2022September 2023Allow1901NoNo
17676339Compositions and Methods of Achieving Pain ReliefFebruary 2022March 2024Abandon2521NoNo
17635248SENSITIZATION CREAM COMPRISING L-ARGININE AND L-CITRULLINE AND THERAPEUTIC USES THEREOFFebruary 2022October 2024Allow3200NoNo
17666294System, Method and Apparatus for Cannabinoid Tincture Separation and Solvent RecoveryFebruary 2022November 2022Abandon1010NoNo
17591914COMPOSITIONS AND METHODS FOR PREDICTING AND PROMOTING WEIGHT LOSS IN PATIENTS WITH LOW AMY1 COPY NUMBERSFebruary 2022February 2026Abandon4921NoNo
17631861CROTON LECHLERI COMPOSITIONS FOR USE IN TREATING BLEEDING, WOUNDS AND INFECTIONSJanuary 2022May 2025Abandon3910NoNo
17586811Method for enhancing skin moisture with white roselle extractJanuary 2022September 2023Allow1910NoNo
17587789TREATMENT OF SEBACEOUS GLAND DISORDERSJanuary 2022April 2025Abandon3901NoNo
17630988FOOD SUPPLEMENT, FOR AS ADJUVANT, FOR PREVENTING VASCULAR DEMENTIAJanuary 2022January 2025Allow3610NoNo

Appeals Overview

This analysis examines appeal outcomes and the strategic value of filing appeals for examiner FIEBIG, RUSSELL G.

Patent Trial and Appeal Board (PTAB) Decisions

Total PTAB Decisions
11
Examiner Affirmed
9
(81.8%)
Examiner Reversed
2
(18.2%)
Reversal Percentile
29.7%
Lower than average

What This Means

With a 18.2% reversal rate, the PTAB affirms the examiner's rejections in the vast majority of cases. This reversal rate is below the USPTO average, indicating that appeals face more challenges here than typical.

Strategic Value of Filing an Appeal

Total Appeal Filings
54
Allowed After Appeal Filing
17
(31.5%)
Not Allowed After Appeal Filing
37
(68.5%)
Filing Benefit Percentile
48.2%
Lower than average

Understanding Appeal Filing Strategy

Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.

In this dataset, 31.5% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is below the USPTO average, suggesting that filing an appeal has limited effectiveness in prompting favorable reconsideration.

Strategic Recommendations

Appeals to PTAB face challenges. Ensure your case has strong merit before committing to full Board review.

Filing a Notice of Appeal shows limited benefit. Consider other strategies like interviews or amendments before appealing.

Examiner FIEBIG, RUSSELL G - Prosecution Strategy Guide

Executive Summary

Examiner FIEBIG, RUSSELL G works in Art Unit 1655 and has examined 903 patent applications in our dataset. With an allowance rate of 62.3%, this examiner allows applications at a lower rate than most examiners at the USPTO. Applications typically reach final disposition in approximately 33 months.

Allowance Patterns

Examiner FIEBIG, RUSSELL G's allowance rate of 62.3% places them in the 22% percentile among all USPTO examiners. This examiner is less likely to allow applications than most examiners at the USPTO.

Office Action Patterns

On average, applications examined by FIEBIG, RUSSELL G receive 1.94 office actions before reaching final disposition. This places the examiner in the 48% percentile for office actions issued. This examiner issues fewer office actions than average, which may indicate efficient prosecution or a more lenient examination style.

Prosecution Timeline

The median time to disposition (half-life) for applications examined by FIEBIG, RUSSELL G is 33 months. This places the examiner in the 46% percentile for prosecution speed. Prosecution timelines are slightly slower than average with this examiner.

Interview Effectiveness

Conducting an examiner interview provides a +22.9% benefit to allowance rate for applications examined by FIEBIG, RUSSELL G. This interview benefit is in the 69% percentile among all examiners. Recommendation: Interviews provide an above-average benefit with this examiner and are worth considering.

Request for Continued Examination (RCE) Effectiveness

When applicants file an RCE with this examiner, 27.9% of applications are subsequently allowed. This success rate is in the 49% percentile among all examiners. Strategic Insight: RCEs show below-average effectiveness with this examiner. Carefully evaluate whether an RCE or continuation is the better strategy.

After-Final Amendment Practice

This examiner enters after-final amendments leading to allowance in 37.1% of cases where such amendments are filed. This entry rate is in the 56% percentile among all examiners. Strategic Recommendation: This examiner shows above-average receptiveness to after-final amendments. If your amendments clearly overcome the rejections and do not raise new issues, consider filing after-final amendments before resorting to an RCE.

Pre-Appeal Conference Effectiveness

When applicants request a pre-appeal conference (PAC) with this examiner, 107.7% result in withdrawal of the rejection or reopening of prosecution. This success rate is in the 78% percentile among all examiners. Strategic Recommendation: Pre-appeal conferences are highly effective with this examiner compared to others. Before filing a full appeal brief, strongly consider requesting a PAC. The PAC provides an opportunity for the examiner and supervisory personnel to reconsider the rejection before the case proceeds to the PTAB.

Appeal Withdrawal and Reconsideration

This examiner withdraws rejections or reopens prosecution in 73.2% of appeals filed. This is in the 62% percentile among all examiners. Of these withdrawals, 56.7% occur early in the appeal process (after Notice of Appeal but before Appeal Brief). Strategic Insight: This examiner shows above-average willingness to reconsider rejections during appeals. The mandatory appeal conference (MPEP § 1207.01) provides an opportunity for reconsideration.

Petition Practice

When applicants file petitions regarding this examiner's actions, 54.3% are granted (fully or in part). This grant rate is in the 55% percentile among all examiners. Strategic Note: Petitions show above-average success regarding this examiner's actions. Petitionable matters include restriction requirements (MPEP § 1002.02(c)(2)) and various procedural issues.

Examiner Cooperation and Flexibility

Examiner's Amendments: This examiner makes examiner's amendments in 1.2% of allowed cases (in the 69% percentile). This examiner makes examiner's amendments more often than average to place applications in condition for allowance (MPEP § 1302.04).

Quayle Actions: This examiner issues Ex Parte Quayle actions in 0.0% of allowed cases (in the 2% percentile). This examiner rarely issues Quayle actions compared to other examiners. Allowances typically come directly without a separate action for formal matters.

Prosecution Strategy Recommendations

Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:

  • Prepare for rigorous examination: With a below-average allowance rate, ensure your application has strong written description and enablement support. Consider filing a continuation if you need to add new matter.
  • Request pre-appeal conferences: PACs are highly effective with this examiner. Before filing a full appeal brief, request a PAC to potentially resolve issues without full PTAB review.

Relevant MPEP Sections for Prosecution Strategy

  • MPEP § 713.10: Examiner interviews - available before Notice of Allowance or transfer to PTAB
  • MPEP § 714.12: After-final amendments - may be entered "under justifiable circumstances"
  • MPEP § 1002.02(c): Petitionable matters to Technology Center Director
  • MPEP § 1004: Actions requiring primary examiner signature (allowances, final rejections, examiner's answers)
  • MPEP § 1207.01: Appeal conferences - mandatory for all appeals
  • MPEP § 1214.07: Reopening prosecution after appeal

Important Disclaimer

Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.

No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.

Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.

Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.